Iberis Amara-Injeel Forte Liq (4d,10d,30d,200d/1.1ml) 4 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02054256) held by Biologische Heilmittel Heel GmbH, containing Iberis Amara. Health Canada lists its status as Cancelled Post Market (status date 20 Jan 1997). Nexara Health has matched 4 registrations of Iberis Amara across 1 other regulated market.
Health Canada registration
| DIN | 02054256 |
|---|---|
| Brand name | Iberis Amara-Injeel Forte Liq (4d,10d,30d,200d/1.1ml) |
| Active ingredient | Iberis Amara |
| Strength | 4 D / 1.1 mL |
| Dosage form | Liquid |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 20 Jan 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Iberis Amara registered in other markets
4 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Iberis amara | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Druppels voor oraal gebruik, oplossing | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Iberis amara | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Iberis amara | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Iberis amara | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Uitsluitend apotheek of drogist | EU national register |
See every manufacturer of Iberis Amara worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Iberis Amara-Injeel Forte Liq (4d,10d,30d,200d/1.1ml) (DIN 02054256) marketed in Canada?
No. Health Canada lists DIN 02054256 as Cancelled Post Market as of 20 Jan 1997.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Iberis Amara registered outside Canada?
Yes — Nexara Health has matched 4 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02054256, status date 1997-01-20; national medicine registries: EU national register. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02054256, status date 1997-01-20; national medicine registries: EU national register.
Health Canada Drug Product Database (DPD), DIN 02054256, status date 1997-01-20; national medicine registries: EU national register. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.